What is the main business of Magnolia Fillers?

The main business activity of Magnolia Fillers focuses on wholesale of pharmaceutical goods.

When was the company founded?

The company was registered in the Polish National Court Register (KRS) on January 12, 2018.

Where is the headquarters located?

The headquarters is located at: ul. Grunwaldzka 87C, 60-312 Poznań.

Who is on the management board?

The management board consists of: Michał Stanisław Lichaj (President of the Management Board).

What is the share capital?

The share capital of the company is PLN 5,000 (approx. $1,351).

What period do the latest financial data cover?

The latest available financial statement covers the period from January 1, 2025 to December 31, 2025.

How much revenue was generated?

The company reported a revenue of $3,009,012 in 2025, which is an increase of 57.2% compared to 2024.

Yes, in 2025 the company was profitable, achieving a net profit of $33,262, meaning the company increased its profit by 159.3%.

What is the largest operating cost?

The largest operating cost category falls under other operating costs. This category amounted to $2,886,757 in 2025, representing 98% of all operating expenses.

Magnolia Fillerssp. z o.o.

Wholesale of pharmaceutical goods

KRS: NIP: REGON:

Overview

Status

Active

Registry date

2018-01-12

Share capital

5,000.00 PLN

Registered address

ul. Grunwaldzka 87C/6, 60-312 Poznań, Poland

Financials

Revenue history (in k)

Filing timeliness

3 of 6 financial statements were filed late (the longest delay 256 days for 2023).

202513/05/2026
202422/07/2025
202328/03/2025
202213/07/2023
202123/06/2022
202023/06/2022

Filed on timeDelayFiling deadline

Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.

Statistics

How the company ranks by revenue within its industry, region and across Poland in 2025.

Results vs industry

Revenue

This companyUSD 3.01mMedianUSD 1.06mAverageUSD 22.41m

Net profit

This companyUSD 33.26kMedianUSD 37.20kAverageUSD 879.46k

Operating costs

This companyUSD 2.95mMedianUSD 921.66kAverageUSD 21.08m

Assets

This companyUSD 259.30kMedianUSD 609.79kAverageUSD 11.85m

Industry

Authorized Representatives

Michał Stanisław Lichaj – President of the Management Board

Manner of representation

Each member of the management board is authorized to make declarations on behalf of the company independently.

Ownership

Owner	Shares	Share value	Stake
Magdalena Lichajage 39	29	$391.68	29%
Michał Stanisław Lichajage 47	29	$391.68	29%
Piotr Jerzy Różańskiage 49	24	$324.15	24%
Others	18	$243.11	18%

Magdalena Lichaj and Michał Stanisław Lichaj hold a combined 58% – the ownership structure indicates family control.

Beneficial owners

Person	Rights

Bank accounts

Registered as a VAT taxpayer on 2020-10-06.

Erste Bank Polska
05 1090 1346 0000 0001 4713 7377
Erste Bank Polska
14 1090 1346 0000 0001 4702 7314
Nest Bank
55 1870 1045 2078 1088 5115 0002

Debt

No entries in the National Debtors Register (KRZ).

Public aid

No public aid cases recorded in the last 10 years.

Competitors

Name	Revenue	Website
Dermaticsp. z o.o.	$33,423,317.64	dermatic.pl
EMS - Euromed Medical Solutionsp. z o.o.	$14,713,557.54	euromed.net.pl
MedaseptS.A.	$8,612,031.18	medasept.pl
PHS Hospitalsp. z o.o. + limited partnership	$1,933,301.24	phs.med.pl
Medaidsp. z o.o.	$1,034,514.88	medaid.pl
Medicallenssp. z o.o.	$179,960.83	medicallens.com
Integris Medical Polskasp. z o.o.	$159,033.76	integrismedical.pl
Aptekssp. z o.o.	$13,537.42	apteks.com
HA Technologiessp. z o.o.	$206.67	amalian.pl
IMS Innovative Medical Solutions Plussp. z o.o.	$0.00	imsmed.pl